Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Raze this is an old PR from 2008.

<< Previous

Bullboard Posts

Next >>

Comment by RazeKreationson Apr 02, 2023 7:31pm

88 Views

Post# 35375125

RE:RE:RE:RE:RE:RE:RE:Raze this is an old PR from 2008.

That's unknown until a deal is reached and reported on what the conditions will be. Its expected that there will be some money up front and a percentage of sales as well as timeframes to meet. Hopefully we will see an agreement this summer. I stress hopefully

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario